Silvercrest Asset Management Group LLC Has $16.78 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Silvercrest Asset Management Group LLC raised its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 24.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 189,115 shares of the company’s stock after acquiring an additional 37,523 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in U.S. Physical Therapy were worth $16,776,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in USPH. CBIZ Investment Advisory Services LLC raised its holdings in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after buying an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of U.S. Physical Therapy in the fourth quarter valued at about $39,000. Venturi Wealth Management LLC raised its holdings in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after buying an additional 704 shares during the last quarter. Lazard Asset Management LLC bought a new stake in U.S. Physical Therapy during the 4th quarter worth about $84,000. Finally, Pacer Advisors Inc. bought a new stake in U.S. Physical Therapy during the 4th quarter worth about $113,000.

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock opened at $79.90 on Friday. The firm has a market capitalization of $1.21 billion, a P/E ratio of 84.99, a PEG ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $107.09. The business has a 50-day moving average of $71.85 and a 200-day moving average of $83.54. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. The company had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company’s revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.51 EPS. On average, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be given a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.25%. U.S. Physical Therapy’s dividend payout ratio is presently 82.57%.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

USPH has been the subject of several recent research reports. JPMorgan Chase & Co. dropped their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, March 19th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Thursday, May 8th. Barrington Research dropped their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a report on Friday, February 28th. William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Finally, JMP Securities reissued a “market outperform” rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average target price of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.